Can low urinary cystathionine indicate reduced transsulfuration throughput?

Cystathionine has a well-established biochemical role in transsulfuration, but a low urine measurement is not a direct measure of pathway flux.

Established biochemical evidence

• Cystathionine is the obligatory intermediate between homocysteine and cysteine. Cystathionine β-synthase (CBS) catalyzes the PLP-dependent 1:1 condensation of homocysteine and serine to form cystathionine and water.
• Cystathionine γ-lyase (CTH/CGL/CSE) then directly converts cystathionine to cysteine, α-ketobutyrate, and ammonia. Thus, cystathionine is an immediate cysteine precursor, not simply an associated metabolite.
• In hepatic cells, oxidative stress can increase cystathionine production, consistent with increased transsulfuration flux to support cysteine availability and intracellular glutathione synthesis.

Mechanistic interpretation of low urinary cystathionine

• Reduced cystathionine production could lower plasma concentrations and filtered renal load, making low urinary excretion compatible with reduced transsulfuration throughput.
• However, low urine cystathionine does not establish that interpretation or exclude greater downstream CTH-mediated conversion. Urinary concentrations reflect filtration and tubular handling in addition to circulating metabolite levels.
• Hydration, creatinine normalization, kidney function/eGFR, diet and substrate availability, medications, laboratory methods, and reference intervals can materially affect the result.

Clinical implications

• An isolated low urinary result should be interpreted alongside plasma cystathionine, homocysteine, cysteine/cystine, PLP (vitamin B6) status, and renal measures; repeating an unexpected result may be useful.
• When pathway flux itself is clinically important, stable-isotope methionine or labeled-serine tracer studies are more direct than urinary metabolite testing.

Bottom line

• The pathway description is strongly supported: CBS forms cystathionine from homocysteine and serine, and CTH converts it toward cysteine. Low urinary cystathionine can be consistent with reduced throughput rather than excess downstream conversion, but it is a nonspecific, low-confidence inference without biochemical and renal-context corroboration.